v3.26.1
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Earnings Per Share [Abstract]    
Net loss attributable to Adaptive Biotechnologies Corporation $ (20,033) $ (29,852)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 155,521,048 149,195,028
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 155,521,048 149,195,028
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.13) $ (0.2)
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.13) $ (0.2)